U.S. Neurosurgical Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 11, 2021 at 04:19 pm EDT
Share
U.S. NeuroSurgical Holdings, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 0 compared to USD 596,000 a year ago. Operating loss was USD 249,000 compared to operating Income of USD 138,000 a year ago. Net loss was USD 574,000 compared to net income of USD 45,000 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 1.061 million compared to USD 1.343 million a year ago. Operating income was USD 428,000 compared to USD 504,000 a year ago. Net loss was USD 35,000 compared to net income of USD 220,000 a year ago.
U.S. NeuroSurgical Holdings, Inc., through its wholly-owned subsidiaries, holds interests in radiological treatment facilities. The Company owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc. Medicare is the federal health insurance program for people ages 65 and over, to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant.
U.S. NEUROSURGICAL HOLDINGS, INC. 
